Analysis showed that MMP3 and SLC2A1 expression were significantly higher in OSA tissue compared to non-tumor tissue and protein expression in OSA was confirmed by immunohistochemistry. This evidence concerns the gene SLC2A1 and obstructive sleep apnea syndrome.